GLUT-1 Expression in Proliferative Endometrium, Endometrial Hyperplasia, Endometrial Adenocarcinoma and the Relationship Between GLUT-1 Expression and Prognostic Parameters in Endometrial Adenocarcinoma

被引:6
|
作者
Canpolat, Tuba [1 ]
Ersoz, Canan [1 ]
Uguz, Aysun [1 ]
Vardar, Mehmet Ali [2 ]
Altintas, Aytekin [2 ]
机构
[1] Cukurova Univ, Sch Med, Dept Pathol, Adana, Turkey
[2] Cukurova Univ, Sch Med, Dept Obstet & Gynecol, Adana, Turkey
关键词
GLUT-1; Prognosis; Endometrial hyperplasia; Endometrioid adenocarcinoma;
D O I
10.5146/tjpath.2015.01352
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: Malignant cells show increased glucose uptake in in vitro and in vivo studies. This uptake is mediated by glucose transporter proteins. GLUT-1 is the most common transporter protein, and its expression is reported to be increase in many human cancers. The aim of this study is to determine the GLUT-1 overexpression in benign, hyperplastic, and malignant endometrial tissues, to evaluate the usefulness of GLUT-1 expression in endometrial hyperplasia, and to determine its role in the neoplastic progression to endometrioid type adenocarcinoma. We also aimed to analyze prognostic clinical parameters, predict prognosis, and survival. Material and Method: We examined immunohistochemical expression of GLUT-1 in 91 cases of endometrial hyperplasia, 100 cases of endometrioid type adenocarcinoma, and 10 proliferative endometrial tissues. The percentage of positive cells and staining intensity were assessed in a semi quantitative fashion and scored (1+ to 3+). Results: GLUT-1 immunoreactivity was not present in proliferative endometrium. Twenty-nine (31.9%) of 91 endometrial hyperplasia cases showed positive immunoreactivity, of which only six were cases of hyperplasia without atypia while 23 of them were cases with atypia. We found GLUT-1 positivity of 95% in endometrioid type adenocarcinoma. GLUT-1 overexpression was not significantly correlated with any of the clinicopathological parameters except histological grade in endometrioid adenocarcinoma; the survival was not found to be correlated with GLUT-1 expression. Conclusion: GLUT-1 immunostaining may be useful in distinguishing hyperplasia without atypia from hyperplasia with atypia; GLUT-1 overexpression is a consistent feature of endometrioid adenocarcinoma. A correlation between GLUT-1 expression and tumor grade has been found, although other prognostic parameters and survival has no meaningful correlation.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [1] GLUT-1 is preferentially expressed in atypical endometrial hyperplasia and endometrial adenocarcinoma
    Ashton-Sager, Amanda
    Paulino, Augusto F. G.
    Afify, Alaa M.
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2006, 14 (02) : 187 - 192
  • [2] GLUT-1 is preferentially expressed in endometrial hyperplasia and adenocarcinoma
    Sager, AA
    Paulino, AF
    Afify, AM
    LABORATORY INVESTIGATION, 2005, 85 : 202A - 203A
  • [3] GLUT-1 is preferentially expressed in endometrial hyperplasia and adenocarcinoma
    Sager, AA
    Paulino, AF
    Afify, AM
    MODERN PATHOLOGY, 2005, 18 : 202A - 203A
  • [4] Expression and significance of β-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma
    Xiong, Y.
    Xiong, Y. Y.
    Zhou, Y. F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2010, 31 (02) : 160 - 164
  • [5] Expression of Glut-1 in Normal Endometrium and Endometrial Lesions: Analysis of 336 Cases
    Nemejcova, Kristyna
    Rosmusova, Jana
    Bartu, Michaela
    Dura, Miroslav
    Ticha, Ivana
    Dundr, Pavel
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2017, 25 (05) : 389 - 396
  • [6] Expression of Glut-1 in endometrial lesions: Analysis of 336 cases
    Nemejcova, K.
    Rosmusova, J.
    Dundr, P.
    Ticha, I.
    Bartu, M.
    Dura, M.
    VIRCHOWS ARCHIV, 2016, 469 : S279 - S280
  • [7] GLUT1 and GLUT8 in endometrium and endometrial adenocarcinoma
    Goldman, Noah A.
    Katz, Ellen B.
    Glenn, Alan S.
    Weldon, Richard H.
    Jones, Joan G.
    Lynch, Uticia
    Fezzari, Melissa J.
    D Runowicz, Carolyn
    Goldberg, Gary L.
    Charron, Maureen J.
    MODERN PATHOLOGY, 2006, 19 (11) : 1429 - 1436
  • [8] Significance of perinecrotic expression of CA9 and Glut-1 in endometrial carcinoma
    Choi, K. -U.
    Pak, M. -G.
    Lee, J. -H.
    Shin, D. -H.
    Sol, M. -Y.
    VIRCHOWS ARCHIV, 2011, 459 : S231 - S231
  • [9] SIGNIFICANCE OF PERINECROTIC EXPRESSION OF CA9 AND GLUT-1 IN ENDOMETRIAL CANCER
    Suh, D.
    Kim, K.
    Yoon, M.
    Lee, Y.
    Kang, S.
    Choi, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [10] Telomerase expression in normal endometrium, endometrial hyperplasia, and endometrial adenocarcinoma
    Shroyer, KR
    Stephens, JK
    Silverberg, SG
    Markham, N
    Shroyer, AL
    Wilson, ML
    Enomoto, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1997, 16 (03) : 225 - 232